The Life Sciences Report

For Love and Money: Three Growth Stocks from Casey's Alex Daley

Thu, 13 Jun 2013 00:00:00 PST

Alex Daley, senior editor of Casey Extraordinary Technology, seeks out undiscovered names because that's where he finds the big upside. In this interview with The Life Sciences Report, Daley brings...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

New Biotech Names with Excellent Prospects: Michael Aitkenhead

Thu, 13 Jun 2013 00:00:00 PST

In a marketplace as diverse as biotech, picking the best and brightest can stymie even the savviest investor. Senior biotechnology analyst and physician Michael Aitkenhead of Edison Investment...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

How to Play the Invest-for-Tomorrow Game in Medtech: Alan Brochstein

Thu, 06 Jun 2013 00:00:00 PST

Alan Brochstein of AB Analytical Services blogs, publishes and creates model portfolios for retail investors and consults with institutional investors. He leans heavily toward medical technology...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Seven Biotech Options that Buck Tradition: Christian Glennie

Thu, 06 Jun 2013 00:00:00 PST

Edison Investment Research assesses the value of emerging companies with a model that assumes revenues and earnings are years away. Then again, every investor does that. What's unusual is that Edison...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

New Perspectives and Seven Biotechs for a Diversified Portfolio: Ori Hershkovitz

Thu, 30 May 2013 00:00:00 PST

Sometimes speaking with investors who work half a world away is just what's needed to get a new angle and hear new names. That was the case when we talked with Ori Hershkovitz, managing partner of...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Diagnostics and Stem Cells Power Productive Portfolios: Kevin DeGeeter

Thu, 30 May 2013 00:00:00 PST

New medical tests can be moneymakers for small- and mid-cap companies: They save insurers the pain of paying more to treat maladies and save patients from unnecessary treatments. In this interview...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Investing in Cancer Research Is Worth the Risk: Echo He

Thu, 23 May 2013 00:00:00 PST

If investigators could find a way to make breast cancer survivors truly cancer free, and if a diagnosis of pancreatic cancer were less dire, investors could reap windfalls while patients and their...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Two Biotech Ideas You May Have Missed: William Gregozeski

Thu, 16 May 2013 00:00:00 PST

Adventurous investors have long sought out micro-cap stocks, attracted by the profit potential of starting on the bottom floor and rocketing toward blue sky. Biotechnology can add even more power to...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Position Yourself for Big Returns in the Stem Cell Space: Jason Kolbert

Fri, 10 May 2013 00:00:00 PST

Stem cell companies have languished long enough in micro-cap territory. The industry is now approaching highly visible phase 2 and phase 3 catalysts that will produce results never before seen in...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Six Superstars for Your Biotech Portfolio: John McCamant

Thu, 09 May 2013 00:00:00 PST

We are in the "golden age," of biotech, and Medical Technology Stock Letter Editor John McCamant has innovative ideas on how to glean profits from the renaissance. Investors should be looking at...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Biotech Watchlist 2013 Update: Exciting Ideas Have Explosive Potential

Thu, 02 May 2013 00:00:00 PST

In January 2013, The Life Sciences Report debuted its biotech Watchlist, which outlined ideas for investors keyed to catalysts in the drug development process that typically move biotechnology...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Biotech Micro Caps Offer Promise of Mighty Returns: Dick Huebner

Thu, 25 Apr 2013 00:00:00 PST

Dick Huebner knows what he wants. He's looking for biotech companies that can make it very big from a near zero-base valuation. We're talking low-end micro caps that bring a lot of risk to the table,...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

What Will It Take for Stem Cell Companies to Close the Valuation Gap?: ARM's Chairman Geoff MacKay

Tue, 16 Apr 2013 00:00:00 PST

Naysayers may harp on the low market valuations of stem cell companies, but Geoff MacKay has an insider's perspective. The Alliance for Regenerative Medicine chairman and Organogenesis Inc. president...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

Companies that Can Mend the Biotech Market: Stephen Brozak

Thu, 11 Apr 2013 00:00:00 PST

Markets are not efficient�at least not in the short term. WBB Securities President Stephen Brozak admits to frustration when he sees small-cap companies with valuations that are disengaged from...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.

6 Biotechs with Staggering Potential: Grant Zeng

Thu, 04 Apr 2013 00:00:00 PST

When it comes to picking biotech stocks, does a buyside perspective matter more than a sellside? Not according to Zacks Investment Research Analyst Grant Zeng, who has straddled the divide. What...

Investors rely on us to share promising investment ideas in a changing world. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the strategies that will help you capitalize on developing sector trends. This valuable insight is integrated with in-depth company information, summaries from the latest research and news that will help you make smart investment decisions.